Evidence map›Paper›PMID 36359507›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Development of a Versatile Half-Strip Lateral Flow Assay toward the Detection of Rift Valley Fever Virus Antibodies.

Thulaganyo Domfe, Zikhona Njengele-Tetyana, Nikiwe Mhlanga, Phumlani Tetyana, Amanda Skepu, Jane Catherine Ngila, Lucky Mashudu Sikhwivhilu

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Thulaganyo DomfeDepartment of Chemical Sciences, University of Johannesburg, Doornfontein, Johannesburg 2050, South Africa.
Zikhona Njengele-TetyanaAdvanced Materials Division, DSI/Mintek NIC, Mintek, 200 Malibongwe Drive, Randburg 2194, South Africa.ORCID 0000-0002-7329-7015
Nikiwe MhlangaAdvanced Materials Division, DSI/Mintek NIC, Mintek, 200 Malibongwe Drive, Randburg 2194, South Africa.
Phumlani TetyanaAdvanced Materials Division, DSI/Mintek NIC, Mintek, 200 Malibongwe Drive, Randburg 2194, South Africa.ORCID 0000-0003-4436-0932
Amanda SkepuNext Generation Health, Council for Scientific and Industrial Research, Meiring Naude Road, Brummeria, Pretoria 0001, South Africa.ORCID 0000-0001-8121-5617
Jane Catherine NgilaDepartment of Chemical Sciences, University of Johannesburg, Doornfontein, Johannesburg 2050, South Africa.
Lucky Mashudu SikhwivhiluAdvanced Materials Division, DSI/Mintek NIC, Mintek, 200 Malibongwe Drive, Randburg 2194, South Africa.ORCID 0000-0003-0972-3785
Mintek · ZAUniversity of Johannesburg · ZACouncil for Scientific and Industrial Research · ZA

Funding

Council for Scientific and Industrial Research NoneDepartment of Science and Innovation (DSI), South Africa NoneDSI/Mintek Nanotechnology Innovation Centre (NIC) NoneMintek NoneThe National Intellectual Property Management Office (NIPMO), South Africa NoneUniversity of Venda None
6 · The paper itself

Abstract

Rift Valley fever (RVF) is a mosquito-borne zoonotic disease that is caused by the Rift Valley fever virus (RVFV);

Indexed as

diagnostic assayenzyme-linked immunosorbent assayprotein expressionRift Valley fever virus

Identifiers

PMID36359507
PMCPMC9689200
OpenAlexW4308766453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.